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Abstract Viability estimation of the highly resistant oocysts of Cryptosporidium remains a key issue 
for the monitoring and control of this pathogen. We present here a simple ‘one tube’ qPCR protocol 
for viability estimation using a DNA extraction protocol which preferentially solubilizes excysted 
sporozoites rather than oocysts. Parasite DNA released from excysted sporozoites was quantified by 
real-time qPCR using ribosomal DNA marker. Using the method, the qPCR signal was directly 
proportional to the number of oocysts excysted, and a power law relationship was noted between 
oocyst age and the proportion excysting. Unexcysted oocysts released negligible amounts of DNA 
making the method suitable for estimating viability of as few as 10 oocysts.  
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Introduction
The apicomplexan genus Cryptosporidium, parasitic in the stomach and  intestine of vertebrate 
hosts, includes several pathogens of humans, the most important of which are the zoonotic C. 
parvum and the human-specific C. hominis, although sporadic infections with other species have also 
been described (Xiao 2010). The dispersive oocysts are shed by infected hosts in large numbers into 
the environment (see e.g. Nydam et al. 2001, Chappell et al. 2006), where they contaminate soil and 
water and pose a threat for human and animal health. The oocysts are highly resistant and easily 
dispersed, and a dose of only 10 may be infective (Zambriski et al. 2013). There is no effective 
treatment and the disease can be fatal for the immunocompromised. Much time and money is 
therefore expended to detect, control and eliminate Cryptosporidium contamination of drinking 
water; for example most recently, in Lancashire, UK in August 2015, 300 000 households were 
advised to boil drinking water for over a week because the parasite had been detected in a water 
treatment plant. A key issue for Cryptosporidium monitoring is that of establishing the viability and 
infectivity of any oocysts found (King and Monis 2007). The gold standard should be to measure the 
potential of oocysts to initiate infections in living hosts, but this is of course impossible under most 
circumstances, and viability is most often assessed by microscopical assays such as vital dye-
exclusion (e.g. Campbell et al. 1992; Jenkins et al. 1997) or in-situ hybridization based on the 
persistence of RNA in living oocysts (Smith et al. 2004), or by bulk assays such as excystation rate 
(Connelly et al. 2007), RNA content estimated by reverse transcription (RT) PCR (Garcés et al. 2006) 
or infectivity for host cell cultures, sometimes monitored by PCR (Shahidauzzaman et al. 2009). 
Quantitative PCR (qPCR) approaches are highly sensitive and avoid the complication of multiple 
handling steps with associated loss of material, which can be a disadvantage when working with 
small numbers of oocysts as may be expected in water monitoring, but of course fail to establish 
viability. Here we describe a simple method for viability estimation, achieved by measuring DNA 
concentration after a simple, one tube excystation-DNA extraction step. Coupled with real-time 
qPCR the method allows reliable, accurate estimation of the proportion of living oocysts in samples, 
and is capable of application to samples of as few as 10 purified oocysts.  
Methods
Oocysts and pre-treatment 
Cryptosporidium parvum IOWA strain oocysts (Waterborne, Inc.) stored in phosphate-buffered saline 
(PBS) supplemented with 100U/ml penicillin, 100 µg/ml streptomycin, 10 mg/ml gentamicin, 0.25 
µg/ml Amphotericin B and 0.01% Tween 20 at 4°C were used in all experiments. Oocysts of different 
age post-purchase from Waterborne Inc. (45, 75, 90, 160, 190 and 300 days old) were used to 
establish a range of samples of different viabilities. The concentration of supplied oocysts was 
initially calculated using a hemocytometer (W. Schreck, Hofheim/TS, Germany), and samples of 
different oocyst concentration (10, 50, 100, 1000, 5000 and 10000 oocysts) generated by dilution. 
The standard excystation protocol (Hijjawii et al. 2001) consisted of incubation of oocysts in a 1.5 ml 
reaction vial (Eppendorf) for 30 minutes at 37°C in a 0.25% trypsin (from bovine pancreas, Sigma, 
cat. no. T1426) solution adjusted to pH 2.5 with 1M hydrochloric acid, followed by centrifugation at 
2000 × g (bench top centrifuge) for 5 minutes. The trypsin solution was replaced by 200 µl of 
Cryptosporidium maintenance medium (Hijjawi et al. 2001, modified as in Paziewska-Harris et al. 
2015) containing 200 µg/ml of bile salts (from bovine and ovine pancreas, Sigma, cat. no. B8381) and 
incubated for a further 2.5 hours at 37°C. Lysis buffer (1 ml; Boom et al. 1990) was added to the 
samples which were stored at 4°C for up to 2 days before DNA extraction. All steps were carried out 
in the same reaction vial, and incubations were performed using heat blocks. Simultaneous with 
every batch of excysted oocysts, a similar control batch of oocysts, which had not been excysted but 
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which had experienced a dummy incubation in 200 µl distilled water, followed by centrifugation and 
incubation in a second aliquot of distilled water was processed.  
DNA isolation 
DNA isolation used a modified technique described by Boom et al. (1990). Following addition of 1 ml 
of the guanidinium thiocyanate based L6 buffer (120 g GuSCN dissolved in 100 ml 0.1 M Tris 
hydrochloride [pH 6.4] and mixed with 22 ml 0.2 M EDTA [pH8.0] and 2.6 g Triton X-100) to the 
oocyst sample, 40 µl of silica (Sigma) size-fractioned as described by Boom et al. (1990) was added 
and the tube shaken for 5 minutes. Subsequently it was centrifuged at 14000 rpm for 30 s, and the 
supernatant discarded. One ml of wash buffer L2 (120 g of GuSCN  dissolved in 100 ml of 0.1 M Tris 
hydrochloride [pH 6.4]) was added to the tube, the contents were mixed by inversion and 
centrifuged again at 14000 rpm for 30 s. Following further rinses with 1 ml of 70% ethanol and 1 ml 
of acetone, with intervening centrifugations (14000 rpm for 30 s), the silica was air-dried and 50 µl of 
sterile water added to the tubes, after which the samples were incubated for 5 min in 56°C to elute 
DNA. After brief centrifugation (14000 rpm for 30 s), eluted DNA was transferred to a new tube and 
stored at -20°C prior to use in real-time qPCR. 
PCR conditions 
Extracted DNA was used as previously described (Paziewska-Harris et al. 2015) in a PCR assay 
targeting a 318 bp fragment of 18S rDNA of Cryptosporidium parvum (bases 453-770, Genbank 
accession L16996). Each amplification reaction consisted of 1× concentrated VeriQuest mix 
(Affymetrics, USA), 0.25 µM of each primer (forward: 5’- GAA ATA ACA ATA CAG GAC TTT TTG GTT 
TTG-3’, reversed: 5’- TTA TTC CAT GCT GGA GTA TTC AAG GCA TAT-3’; Biolegio, The Netherlands), 
0.12 µM probe (5’ FAM [6-carboxyfluorescein]-TAC GAG CTT TTT AAC TGC AAC AA-XS-BHQ[Black 
Hole Quencher] 3’; Biolegio, The Netherlands) and 1.25 µl of DNA in 12.5 µl of final volume. With 
each set of reactions a negative control (sterile water) and a standard curve for quantification of the 
parasites were used. The standard curve was based on DNA isolated from Cryptosporidium
sporozoites.  The physical concentration of oocysts and sporozoites was calculated by pipetting  10 
µl of oocysts or freshly-excysted sporozoite suspension  between the counting chamber and cover 
slide of a hemocytometer (W. Schreck, Hofheim/TS, Germany). After a 5-minute settlement period,  
parasites were counted using an inverted microscope at 100× magnification. A total of 25  0.004 
mm3 squares of the chamber were counted, giving a total counting volume of 0.1 mm3 (=0.1 µl). 
After multiplying by 10, the concentration of parasites/µl was obtained, and a 10-fold dilution series 
prepared from 8000 parasites/µl down to 0.08 parasites/µl. The thermal profile of the PCR reaction 
was: 50°C for 10 min (for Uracil-DNA glycosylase activation), 95°C for 10 min, 50 cycles of 95°C for 15 
s and 60°C for 1 min, with a plate read after each cycle, and the reactions were performed in CFX96 
TouchTM real-time PCR blocks (BioRad, USA). 
Results
The PCR assay was able to detect between 0.4 and 4 copies of 18S rDNA/µl (Fig. 1), which translates 
to a concentration of between 0.08 and 0.8 sporozoite per µl of DNA elution buffer, given that each 
sporozoite contains 5 copies of 18S rDNA (Abrahamsen et al. 2004). The signal in qPCR for 4 copies 
of 18S rDNA/ µl was obtained with a frequency of 92% with Ct (cycles to threshold) value of 36.08 to 
38.83, while the signal from 0.4 copies was obtained in 29% cases with a Ct value of 36.21 to 38.54. 
On all graphs the estimated number of oocysts has been calculated on the basis that one oocyst 
contains 4 sporozoites. The standard curve shows a sensitivity of the qPCR for as few as 1 sporozoite 
in the PCR reaction. At the lowest DNA concentration, the lowest threshold cycle for the qPCR is 
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around cycle 36-39, and at this concentration the reaction worked in 7/24 reactions, consistent with 
the inclusion of a template DNA copy in 30% of all reactions. 
Oocysts exhibit a sharp decline in viability, as measured by their ability to excyst, after storage at 
4°C. Following 45 days storage, 95% of oocysts remain able to excyst, but there is then a rapid 
decline in excystation rate to 14% for the 75-day-old oocysts (see Fig. 2a). This loss of viability can be 
modelled by a power curve (the best model indicated by Bayesian information criterion [BIC]): 
where y= estimated number of oocysts and x= age of oocysts, with a linear correlation coefficient 
(R2) for the log transformed equation of 0.73 (Fig. 2b). Estimation of the DNA concentration of 
unexcysted control oocysts, which had not been pre-treated with trypsin and bile salts, was between 
0.1-1.8% of the original input, regardless of the age of oocysts (Fig. 2c). 
For oocysts stored at 4°C for 60 days and then excysted, the relationship between the number of 
inputted oocysts and qPCR-based DNA estimation was linear (choice of the model based on BIC), 
with an R2 of 0.875 (Fig. 3a). Based on this linear relationship, the proportion of oocysts releasing 
viable sporozoites was predicted by the equation  
where y = the number of emerging sporozoites and x = the input dose of oocysts, suggesting a 
viability for the oocysts of c. 31%, compared to a predicted viability of 30% from Fig. 2b.  For oocysts 
which had been stored for 75 days, the fitted equation 
had an R2 of 0.94 (Fig. 3a); the coefficient of 0.175 suggests a viability of 17%; the predicted viability 
of these cysts (Fig. 2b) was 14%. In all cases however, the viability estimated from individual 
replicates varied between 35% and 65% for the 60d old oocysts and 8% and 31% for the 75d oocysts. 
The signal from unexcysted oocysts corresponded to a sporozoite yield ranging from 0 for the lowest 
input up to 100 for the input of 10000 60-day old oocysts, and up to 600 for an input of 10000 75-
day cysts (Fig. 3a,b). 
Discussion
The current methodology represents a one-tube approach to estimate small numbers of oocysts 
with minimal wastage, and could detect DNA from viable Cryptosporidium oocysts in samples of as 
few as 10 oocysts. The sensitivity of the reaction was at least as good as that shown for RT-PCR by 
Guy et al. (2003), and represents as sensitive a detection methodology for living Cryptosporidium as 
any currently available. The key step is the excystation of oocysts and the extraction of sporozoite 
DNA within a single tube, avoiding the need for either the extraction of DNA from oocysts, or the 
conversion of extracted RNA to cDNA (Guy et al. 2003), both methodologies requiring high efficiency 
extraction of nucleic acids from oocysts. The high sensitivity and one-tube protocol strongly 
recommend the method for the evaluation of Cryptosporidium viability based on small cyst counts, 
such as are obtained from water or soil samples. The detection of DNA from excysted sporozoites 
from small samples (100 or 10 oocysts) was stochastic, but this will always be an issue with very 
small numbers of oocysts; within samples, viable oocysts must be present, and when present, the 
DNA from the excysted sporozoites must be present in the PCR reaction. We recommend that when 
estimating viability from as few as 100 or 10 oocysts, the number of PCR replicates performed on the 
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5 
template be correspondingly increased, to allow viability to be estimated according to the Poisson 
distribution of positive reactions.  
Testing of the method on the oocysts of different age gave the results similar with those observed by 
Liang and Keely (2012) based on mRNA analysis, where oocysts stored for 3 months at 4°C in PBS 
showed just under 35% viability as compared to the fresh ones, and after 11 months the loss of 
viability increased to 99% (compared to 99.5% after 10 months as estimated in our study). This 
suggests that the method of estimating viability described in this study can be used with similar 
precision as methods based on the RNA analysis. 
The current methodology also highlights the great problem with nucleic acid extraction from 
Cryptosporidium; the difficulty experienced in solubilizing the oocyst. The current methodology uses 
the Boom protocol (Boom et al. 1990) for nucleic acid extraction, which is based on the solubility of 
proteins in guanidinium thiocyanate (GuSCN).  Guanidinium thiocyanate is a potent chaotropic agent 
capable of solubilizing almost any protein substrate, and the failure of oocysts to dissociate in the 
extraction buffer in this methodology is probably connected with specific composition of outer 
layers of oocyst wall (glycocalyx and lipid hydrocarbon; see e.g. Jenkins et al. 2010 for details), which 
are not disrupted by GuSCN. Furthermore, the Boom et al. (1990) protocol does not include a 
reducing agent (e.g. 2-mercaptoethanol) with the guanidinium reagent, and possibly for this reason 
the lysis buffer is unable to break down disulphide bonds within the protein component of the 
oocyst cell wall, which adds to its resistance. Instead, intact unexcysted oocysts are removed during 
the silica-binding and subsequent washes of the Boom (1990) protocol, and the final extracted DNA 
is derived only from excysted sporozoites, with at most 1% of the DNA template being derived from 
unexcysted oocysts (Fig. 3).  Commercial column methodologies which include reducing agents may 
not work in this same manner, and the vagaries of local concentration of reductants in, for example, 
faecal extractions, could lead to considerable errors in Cryptosporidium oocyst estimation based on 
total DNA. At the same time, commercial kits elute nucleic acids in larger volumes, and often do not 
employ a single tube. In the current protocol, the elution volume could be reduced when dealing 
with particularly small samples.  
A further issue with the methodology concerns an apparent decline in viability/sporozoite 
abundance at the highest oocyst concentrations. This does not appear to be an issue with DNA 
binding because the highest standard on the standard curve utilized a similar oocyst number than 
the maximum number excysted in the experimental series. One possibility is that parasite DNA  
binds to glycoproteins (Liu et al. 2010) in oocyst fragments in the medium, potentially reducing total 
apparent DNA abundance at the highest oocyst concentrations. However, since the method is 
designed for, and is most effective with very small oocyst numbers, in practice this saturation effect 
should not be important.  
The current method is several orders of magnitude more sensitive than microscopy, and much less 
labor-intensive, requiring far fewer washing and staining steps. It is also a more relevant measure of 
viability; it measures the success of a vital process, excystation, rather than a proxy such as energy 
supply or mRNA pools. Being based in a single reaction vial with minimal washes to cause oocyst 
loss, it is simple and capable of incorporation into routine screening protocols for Cryptosporidium in 
environmental samples. Linked to, for example, magnetic bead technology to isolate and 
concentrate oocysts, we envisage the method providing a significant improvement in assessment of 
viability of Cryptosporidium recovered from a variety of sources including ground water, soil and 
animal faeces. 
Conflict of Interest: The authors declare that they have no conflict of interest. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
References
Abrahamsen MS, Templeton TJ, Enomoto S, Abrahante JE, Zhu G, Lancto CA, Deng M, Liu C, Widmer 
G, Tzipori S, Buck GA, Xu P, Bankier AT, Dear PH, Konfortov BA, Spriggs HF, Iyer L, Anantharaman V, 
Aravind L, Kapur V (2004) Complete genome sequence of the apicomplexan, Cryptosporidium 
parvum. Science 304:441-445. doi: 10.1126/science.1094786
Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J (1990) 
Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28:495-503 
Campbell AT, Robertson LJ, Smith HV (1992) Viability of Cryptosporidium parvum oocysts: correlation 
of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Appl Environ Microbiol 
58:3488-3493  
Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S, Tzipori S (2006) 
Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 75:851-857  
Connelly SJ, Wolyniak EA, Dieter KL, Williamson CE, Jellison KL (2007) Impact of zooplankton grazing 
on the excystation, viability and infectivity of the protozoan pathogens Cryptosporidium parvum and 
Giardia lamblia. Appl Environ Microbiol 73:7277-7282. doi: 10.1128/AEM.01206-07 
Garcés G, Effenberger M, Najdrowski M, Wackwitz C, Gronauer A, Wilderer PA, Lebuhn M (2006) 
Quantification of Cryptosporidium parvum in anaerobic digesters treating manure by (reverse-
transcription) quantitative real-time PCR, infectivity and excystation tests. Water Sci Technol 53:195-
202. doi: 10.2166/wst.2006.250
Guy RA, Payment P, Krull UJ, Horgen PA (2003) Real-time PCR for quantification of Giardia
and Cryptosporidium in environmental water samples and sewage. Appl Environ Microbiol 69:5178-
5185. doi: 10.1128/AEM.69.9.5178-5185.2003
Hijjawi NS, Meloni BP, Morgan UM, Thompson RCA (2001) Complete development and long-term 
human and cattle genotypes in cell culture. Int J Parasitol 31:1048-1055. doi: 10.1016/S0020-
7519(01)00212-0  
Jenkins MB, Anguish LJ, Bowman DD, Walker MJ, Ghiorse WC (1997) Assessment of a dye 
permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts. Appl 
Environ Microbiol 63:3844-3850  
Jenkins MB, Eaglesham BS, Anthony LC, Kachlany SC, Bowman DD, Ghiorse WC (2010) Significance of 
wall structure, macromolecular composition and surface polymers to the survival and transport of 
Cryptosporidium parvum oocysts. Appl Environ Microbiol 76:1926-1934. doi: 10.1128/AEM.02295-09 
King BJ, Monis PT (2007) Critical processes affecting Cryptosporidium oocyst survival in the 
environment. Parasitology 134:309-323. doi: 10.1017/S0031182006001491 
Liang Z, Keeley A (2012) Comparison of propidium monoazide-quantitative PCR and reverse 
transcription quantitative PCR for viability detection of fresh Cryptosporidium oocysts following 
disinfection and after long-term storage in water samples. Water Research 46:5941-5953. doi: 
10.1016/j.watres.2012.08.014
Paziewska-Harris A, Singer M, Schoone G, Schallig H (2015) Quantitative analysis of Cryptosporidium
growth in in vitro culture – the impact of parasite density on the success of infection. Parasitol Res 
115:329-337. doi: 10.1007/s00436-015-4751-1  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
7 
Shahiduzzaman M, Dyachenko V, Obwaller A, Unglaube S, Daugschies A (2009) Combination of cell 
culture and quantitative PCR for screening of drugs against Cryptosporidium parvum. Vet Parasitol 
162:271-277. doi: 10.1016/j.vetpar.2009.03.009 
Smith JJ, Gunasekera TS, Barardi CRM, Veal D, Vesey G (2004) Determination of Cryptosporidium 
parvum oocyst viability by fluorescence in situ hybridization using a ribosomal RNA-directed probe. J 
Appl Microbiol 96:409-417. doi: 10.1046/j.1365-2672.2004.02150.x 
Xiao L (2010) Molecular epidemiology of cryptosporidiosis: an update. Exp Parasitol 124:80-89. doi: 
10.1016/j.exppara.2009.03.018
Zambriski JA, Nydam DV, Wilcox ZJ, Bowman DD, Mohammed HO, Liotta JL (2013) Cryptosporidium 
parvum: Determination of ID50 and the dose-response curve in experimentally challenged dairy 
calves. Vet Parasitol 197:104-112. doi: 10.1016/j.vetpar.2013.04.022 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
8 
Fig. 1 Standard curve for qPCR targeting Cryptosporidium 18S rDNA based on a 10-fold dilution series 
of 40000 copies. Linear regression (y = -1.272ln(x) + 37.325, R2 = 0.997) shown as dashed line. 
Fig. 2 Comparison of oocysts of different ages; a) mean number of oocysts excysting (initial number 
treated = 8650) following trypsin/bile salts pre-treatment, estimated by qPCR performed on DNA 
obtained from the total sample; b) decline in excystation success of trypsin/bile salt pre-treated 
oocysts, based on qPCR of DNA from the total sample, plotted on a logarithmic scale. Regression 
(dashed line) follows the equation y = 2 × 108 × x-2.747 (R2 = 0.73); c) estimation of total oocyst 
number (without pre-treatment).  Note that the logarithmic scale is one order of magnitude smaller 
than in (b), and the variability of DNA estimation due to inefficiency of extraction from oocysts.   
Fig. 3 Comparison of the number of oocysts excysting based on qPCR-estimation of Cryptosporidium
DNA from a) trypsin/bile salt pre-treated (circles) and untreated (diamonds) 60-day (open markers, 
dashed trendline) and 75-day (solid markers, solid trendline) oocysts; equations for the trendlines 
given in text; b) 60-day (open columns) and 75-day (solid columns) old oocysts liberating DNA (mean 
± SD , based on minimum of 3 replicates) without pre-treatment to stimulate excystation. Note the 
difference in scale between (a) and (b). 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Figure 1 Click here to download Figure Fig-1.tif 
Figure 2 Click here to download Figure Fig 2.tif 
Figure 3 Click here to download Figure Fig 3.tif 
